Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Safety related drug-labelling changes: findings from two data mining algorithms.

Manfred Hauben1, Lester Reich

  • 1Risk Management Strategy, Pfizer Inc, New York, New York 10017, USA.

Drug Safety
|September 8, 2004
PubMed
Summary

Proportional reporting ratios (PRRs) detected more drug-event combinations than the multi-item gamma Poisson shrinker (MGPS) algorithm. PRRs also identified safety signals earlier, highlighting the need to consider signal timing and clinical relevance over volume.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis.

Drug safety·2026
Same author

Verbal Expressions of Probability in Pharmacovigilance: Most Likely Too Ambiguous.

Clinical therapeutics·2026
Same author

A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements.

Drug safety·2026
Same author

Perspective on Better Access to Data and Data Integration in Pharmacovigilance: Information from a Focus Group.

Drug safety·2026
Same author

How LLMs can advance safety case intake-points to consider and insights from a proof of concept.

Therapeutic advances in drug safety·2025
Same author

Current Approaches in Postapproval Vaccine Safety Studies Using Real-World Data: A Systematic Review of Published Literature.

Clinical therapeutics·2024

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Computational Toxicology
  • Biostatistics

Background:

  • Postmarketing safety surveillance relies on data mining algorithms (DMAs) to detect drug-event signal disproportionality in spontaneous reporting systems (SRS).
  • Comparative performance of different DMAs, such as proportional reporting ratios (PRRs) and Bayesian methods like multi-item gamma Poisson shrinker (MGPS), is critical for effective signal detection.
  • Bayesian methods may offer a reduction in false-positive signals compared to simpler disproportionality analyses.

Purpose of the Study:

  • To compare the performance of two well-established DMAs: proportional reporting ratios (PRRs) and multi-item gamma Poisson shrinker (MGPS).
  • To evaluate these algorithms using standard thresholds on adverse events linked to drug labeling changes.
  • To assess signal generation timing and the clinical nature of events flagged by each DMA.

Related Experiment Videos

Main Methods:

  • Retrospective application of PRRs and MGPS to a diverse set of drug-event combinations (DECs) from a government website over a 7-month period.
  • Analysis of the number and proportion of DECs generating signals by PRR, MGPS, both, or neither.
  • Comparison of the timing of signal generation and the clinical characteristics of flagged events.

Main Results:

  • PRRs identified nearly twice as many DECs (77) as MGPS (40) that triggered safety-related labeling changes.
  • No DECs were exclusively flagged by MGPS; PRRs consistently flagged DECs earlier than MGPS (1-15 years prior to MGPS signal, 1-30 years prior to label change).
  • 59 DECs did not generate a signal with either DMA; PRR-only signals included both serious and non-serious events.

Conclusions:

  • PRRs detected more signals and did so earlier than MGPS, but this volume alone is not a sufficient comparison metric.
  • The clinical nature of signalled events and the differential timing of signal detection are crucial factors for evaluating DMA utility.
  • Commonly recommended thresholds for PRRs and MGPS may not be universally applicable benchmarks for signal detection.